Dr. Chetan Kalal Honored by Dadasaheb Phalke Chitrapat Union; Recognized for Excellence in Hepatology and Liver Care

Hepatology consultation — Dr. Chetan Kalal, liver specialist, Gleneagles Hospital Mumbai
In a rare convergence of medicine and mainstream recognition, Dr. Chetan Kalal, Consultant

Hepatologist at the Institute of Liver Diseases, Mumbai, has been honored by the Dadasaheb Phalke Chitrapat Union in 2025 for his contributions to liver medicine and public health awareness.

While traditionally associated with cinematic excellence, the recognition reflects the growing acknowledgment of healthcare professionals whose work significantly impacts society.

Academic & Professional Background

Dr. Kalal hails from the Khandesh region of Maharashtra and completed his MBBS in Dhule before moving to Mumbai in 2007 to pursue his MD at KEM Hospital. He later obtained his DM in Hepatology from the Institute of Liver and Biliary Sciences (ILBS), New Delhi — becoming Maharashtra’s first DM Hepatologist
He has also undergone advanced clinical exposure in the United States and the United
Kingdom, strengthening his expertise in complex liver disorders and transplant hepatology

Clinical Expertise

Dr. Kalal manages the full spectrum of liver diseases, including:
  • Metabolic dysfunction-associated steatotic liver disease (MASLD)
  • Alcohol-related liver disease
  • Viral hepatitis (B & C)
  • Cirrhosis and portal hypertension
  • Liver cancer
  • Liver transplant evaluation and pre/post-transplant care
His practice emphasizes early fibrosis detection, metabolic risk correction, and evidence-based intervention.

Research & International Recognition

Dr. Kalal has authored over 40 peer-reviewed scientific publications in national and international medical jourals.
He is a two-time recipient of the prestigious American Association for the Study of Liver Diseases (AASLD) Foundation Award, oe of the highest recognitions in global hepatology research.
In addition to academic publications, he has actively contributed to international clinical trials aimed at advancing therapies for chronic liver disease.

Liver Transplant Landscape in India

India performs approximately 5,000 liver transplants annually, with nearly 90% being living donor transplants. When performed at experienced centers and at appropriate clinical timing, urvival rates approach 90–95%.
Dr. Kalal emphasizes timely referral, structured evaluation, and multidisciplinary management as key determinants of transplant outcomes.

Public Health Advocacy

With India witnessing a sharp rise in lifestyle-driven liver disease, Dr. Kalal activelypromotes awareness regarding:
  • Early fibrosis screening
  • Diabetes and fatty liver linkage
  • Alcohol-related liver injury
  • Avoidance o
  • Preventive vaccination for viral hepatitis
  • unsupervised medication use

He regularly engages in public education initiatives focused on prevention and early diagnosis.

Recognition Beyond Medicine

The Dadasaheb Phalke Chitrapat Union honor represents a symbolic acknowledgment of the role physicians play in afeguarding public health. It underscores the intersection of discipline, dedication, and societal impact beyond conventional professional boundaries.

From his beginnings in Khandesh to national and international recognition Dr. Chetan Kalal’s career reflects a sustained commitment to clinical excellence, research advancement, and ethical patient care.

About the Author

Dr. Chetan Kalal — MBBS, MD (Internal Medicine), DM Hepatology (ILBS, New Delhi) — is the First DM Hepatologist of Maharashtra and Associate Director, Hepatology & Liver Transplant, at Gleneagles Hospital Mumbai. He has 26 peer-reviewed publications and serves on the APASL AARC Expert Panel. Fellow, National Academy of Medical Sciences (FNAMS). Learn more · Book appointment

Book AppointmentDr. Chetan Kalal · Hepatologist